W.R. Berkley’s Aimei Health Technology AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$470K Buy
+38,826
New +$508K 0.02% 276
2025
Q4
– Sell
-450,655
Closed -$5.1M – 286
2025
Q3
$5.1M Buy
450,655
+25,294
+6% +$284K 0.29% 64
2025
Q2
$4.7M Buy
425,361
+81,235
+24% +$900K 0.25% 80
2025
Q1
$3.79M Sell
344,126
-99,753
-22% -$1.08M 0.22% 70
2024
Q4
$4.75M Buy
+443,879
New +$4.69M 0.19% 54

Other funds holding AFJK

W.R. Berkley's AFJK Position: Q3 2026 in Review

W.R. Berkley opened a new position in Aimei Health Technology (AFJK) in Q3 2026: 38,826 shares worth $470K. The stake represents 0.02% of the portfolio and ranks #276 among its holdings. This is a return to the name: W.R. Berkley previously reported a position in AFJK as recently as Q3 2025.

W.R. Berkley first reported a position in AFJK in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.1M in Q3 2025. 7 funds tracked by Wall St. Rank hold AFJK as of Q3 2026.

  • W.R. Berkley held 38,826 shares of Aimei Health Technology worth $470K as of Q3 2026.
  • Aimei Health Technology was a new W.R. Berkley position in Q3 2026.
  • Aimei Health Technology made up 0.02% of W.R. Berkley's portfolio in Q3 2026, its #276 holding.
  • W.R. Berkley first reported a position in Aimei Health Technology in Q4 2024 and has held it in 5 quarters since.
  • W.R. Berkley's Aimei Health Technology position peaked at $5.1M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Aimei Health Technology as of Q3 2026.

Based on W.R. Berkley's 13F filing for Q3 2026, filed 16 Nov 2026.